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Abstract 
Armet is a bifunctional protein widely distributed in animal species, vertebrate and 
invertebrate. It is an evidently part of the Unfolded Protein Response (UPR) and promotes 
survival in cells that are under endoplasmic-reticulum (ER) stress. It has also been found as a 
secreted protein with neurotrophic activity. The crystal and solution structures of human Armet 
show it is a helix-rich protein with two domains linked through a flexible linker region. In this 
study, immunofluorescence staining was used to verify Armet’s localization in ER and Golgi 
apparatus in MBA-MD-231 cells. Evidence for calcium binding by Armet was obtained by 
circular dichroism spectroscopy (the binding of calcium appeared to decrease helix content), by 
differential scanning calorimetry (binding of calcium resulted in a less structured protein) and 
two-dimensional (
1
H-
15
N HSQC) nuclear magnetic resonance spectroscopy.  A difference HSQC 
spectrum of Armet, with and without calcium, showed peaks of increased intensity, of decreased 
intensity and of perturbed chemical shift.  There were about 30 such peaks in total.  Several of 
these affected amino acid residues appeared to form a cluster of negatively charged side chains 
that could possibly form a binding site for a calcium ion. Heterogeneity of three types was 
observed in recombinant Armet expressed in E. coli cells.  Two bands of slightly different 
mobility were observed in SDS gels run in the absence of reducing agent. These may represent 
alternate arrangements of disulfide bonds, as previously reported by other investigators but not 
explained. Further, in the absence of reducing agent, a faint ladder was formed by human Armet, 
indicating formation of disulfides between Armet molecules. Oligomers with sedimentation 
coefficient greater than the monomeric protein, in the absence of reducing agent, disappeared in 
the presence of a reducing agent. Finally, minor species of mass differences of 98 and 180 with 
respect to the main protein component were observed by MALDI-TOF mass spectrometry. 
These studies provide a more thorough characterization of Armet than has been previously 
available and set the scene for future investigations of the binding of organic ligands to the 
protein.   
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Chapter 1 - Introduction 
 Armet: the protein and its names 
A cDNA encoding a protein with 234 amino residues was identified from human 
chromosomal band 3p21.1 (Shridhar et al., 1996). The encoded protein was first named arginine-
rich protein (ARP) because it appeared to contain 22 arginines in the first 55 residues. This 
protein was also believed to be “mutated in early stage of tumors” and was therefore named 
Armet when mutants if it were found in a variety of cancers such as head and neck, lung, breast, 
prostate, and pancreatic cancers (Shridhar et al., 1996, 1997). However, a later study (Evron et 
al., 1997) showed that the variations of ARP’s sequence in tumors represented normal 
polymorphisms rather than tumor-specific mutations. Since the name “Armet” was kept and still 
used in later publications, it will be used in this thesis. 
Armet protein was not purified or cloned until 2003. Petrova et al. (2003) isolated a 
neurotrophic factor secreted by human ventral mesencephalic cell line 1 (VMCL1), which was 
partially identical in sequence to Armet but only contained 179 residues. It was then clear that 
the originally predicted arginine-rich region of the transcript was not translated. Armet was 
instead secreted after cleavage of a 21 residue, N-terminal signal peptide. Petrova et al. (2003) 
gave Armet the alternative name of mesencephalic, astrocyte-derived neurotrophic factor 
(MANF) (Petrova et al., 2003). Glycosylation of Armet expressed in HEK293 cells was reported 
(Petrova et al., 2003), but in later studies (Mizobuchi et al., 2007; Lindholm et al., 2008), 
modified human and mouse Armet were not detected. 
 Unfolded protein response (UPR) 
Endoplasmic reticulum (ER) is an important organelle for nascent secretory and 
transmembrane protein folding and posttranslational modification. When the physiological 
homeostasis of ER is perturbed, signal pathways will be activated to increase the biosynthetic 
capacity and decrease the biosynthetic burden. And these pathways are called UPR (Ma et al., 
2004, Schroder et al., 2005, Kim et al., 2008). The unfolded proteins are recognized by Bip, 
UGGT and other less known ER chaperones. Binding of unfolded protein and chaperones 
activates three ER membrane proteins: PERK, IRE1, and ATF6 (Schroder et al., 2005). 
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Phosphorylation of eIF-2α by PERK results in general inhibition protein synthesis. IRE1 causes 
the mRNA splicing of XBP1, which is an important transcription factor regulating expression of 
gene in ER stress. Activation of ATF6 upregulates chaperone expression (Ma et al., 2004).  
 Armet’s function in ER stress 
Several studies have indicated that Armet is a part of the UPR during ER stress induced 
cell death (Mizobuchi et al., 2007, Apostolou et al., 2008, Tadimalla et al., 2008, Hellman et al., 
2010, Yu et al., 2010). Armet’s gene was first found to be ER-stress-induced from expression 
microarray analysis (Apostolou et al., 2008). Knockdown of Armet mRNA by siRNA treatment 
of Hela cells rendered the cells more susceptible to ER stress-induced death. Overexpression of 
Armet improved cell viability under glucose-free starvation and in ER stress (Apostolou et al., 
2008). Armet levels were detected to be increased by tunicamycin and thapsigargin induced ER 
stress along with another well-known ER stress response protein, Grp78 (Bip) (Apostolou et al., 
2008), Armet’s mRNA and protein expression patterns were similar to Grp78’s (Mizobuchi et al., 
2007). 
In ischemia, ER stress leads to protein misfolding caused by the low oxygen level 
(Kumar et al., 2001; Paschen et al., 2003; Morimoto et al., 2007; Oida et al., 2008; Yu et al., 
2010). Protein level of Armet was found to be increased by cerebral ischemia (Apostolou et al., 
2008; Yu et al., 2010). An increased Armet mRNA level was detected along with induced 
protein expression in heart ischemia (Tadimalla et al., 2008). Addition of recombinant Armet in 
culture medium protected cultured cardiac myocytes from stimulated ischemia/ reperfusion-
mediated death (Tadimalla et al., 2008), and injection of recombinant Armet in cerebral cortex 
reduced ischemic brain injury and promoted behavioral recovery in rats (Airavaara et al., 2009).  
Armet’s detailed or specific role is not known. For instance, it is not known what binds to 
Armet. Armet’s promoter contains one putative ER stress response element (ERSE) (Tadimalla 
et al., 2008), and an ERSE-II region which contains two transcription factor recognition 
sequences for recognition by ATF6/ XBPI, and NF-Y (Mizobuchi et al., 2007; Tadimalla et al., 
2008). Human Armet also has a C-terminal RTDL sequence for ER retention(Apostolou et al., 
2008). 
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 Armet as a neurotrophic factor (MANF) 
As a neurotrophic factor, Armet (MANF) selectively protected nigral dopaminergic 
neurons, but not GABAergic or serotonergic neurons (Petrova et al., 2003). Armet (MANF) is a 
homolog to dopamine neurotrophic factor (CDNF) (Lindholm et al., 2007). Receptors of these 
two proteins are unknown. Later studies suggested Armet (MANF) promotes neuron 
proliferation (Yu et al., 2010) and protects neurons intracellularly as efficiently as Ku70 
(Hellman et al., 2010). Voutilainen et al. (2009) suggest Armet (MANF) to be a new target for 
Parkinson’s disease therapy and their preliminary data has shown its neurorestorative function in 
a rat model.  
 Armet’s structure 
Crystal and solution structures of human Armet, and the solution structure of mouse 
Armet have been published (Fig. 1.4). The first was obtained by X-ray crystallography and only 
contained residues 1 to 137 due to the lack of electron density in the C-terminal area. Armet 
crystallized as a monomer at neutral pH. There are five α-helices followed by a turn of З10 helix 
in the N-terminal region (residues 1-95). Residues 111-137 of the C-terminal region contain two 
α-helices and are connected with the N-terminal region by a loop or linker (residues 95-111). 
Three disulfide bridges formed (Cys6-Cys93, Cys9-Cys82, and Cys40-Cys51) were found in the 
N-terminal domain. Another (Cys123-Cys130) was found in C-terminal domain (Parkash et al., 
2009). 
Structural alignment based on crystal structure of Armet suggested that the N-domain had 
a saposin-like structure, and C-terminal domains have one CXXC motif which is often observed 
in reductases and disulphide isomerases (Parkash et al., 2009). 
Hellman et al. (2010) obtained a solution structure of human Armet by NMR (Fig. 1.5, 
Fig. 1.6). In this structure, the protein contained three parts: an N-terminal domain (residues 1-
95), a linker region (residues 96-103), and a C-terminal domain (residues 104-158). The N-
terminal domain contained five α-helices and one З10 helix. The C-terminal domain contained 
one loosely formed α-helix followed by two parallel α-helices. Eight cysteines in the mature 
protein all formed disulfide bonds. The arrangement of disulfide bonds was consistent with result 
obtained in the X-ray crystallography study (Prakash et al., 2009). Low heteronuclear 
1
H-
15
N 
NOE values indicated the linker region, residues 1-4 and residues 148-158 were highly flexible. 
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The structure of residues 96-158, expressed independently, is identical to the same region in full-
length protein (Hellman et al., 2010). No NOE signals were observed between the two domains 
indicates a relatively high fluctuation between orientations of these two domains or a wide 
separation between the two domains (Hellman et al., 2010).  
Structural superimposition showed the C-domain was structurally similar to members of 
the SAP (SAF-A/B, Acinus and PIAS) protein superfamily (Hellman et al., 2010). Although 
Armet and Ku70 share high structural similarity, and have similar protective function toward 
neurons, it is not clear whether Armet can bind Ku70’s ligand, which is Bcl-2-associated X 
protein (BAX) (Hellman et al., 2010). 
The structure of mouse Armet has also been solved by NMR. Mouse Armet has 97% 
sequence identity with human Armet (Fig. 1.2, Fig. 1.5, Fig. 1.6). The N-terminal domain of 
mouse Armet is comprised of six helices. Four helices (α1, α2, α4, π) constitute a bundle-like 
structure followed by α3 and З10 helices. The π helix is always involved in ligand/enzyme 
substrates binding. More interestingly, the negatively charged residues in the π-helix are not 
conserved as other positively charged residues on other part of the N-domain. Signal broadening 
in the HSQC spectrum indicates the linker region is flexible. 
15
N spin-relaxation parameters 
suggest N- and C- domains are connected by a flexible linker and tumble independently (Hoseki 
et al., 2010). These observations agree with the NMR study of human Armet (Hellman et al., 
2010). Four disulfide bounds were found in the NMR study of mouse Armet and the result was 
verified by MALDI-TOF MS. But in an earlier MALDI-TOP MS study of mouse Armet 
(Mizobuchi et al., 2007), C6 formed a disulfide bond with C9 instead of C93, and C93 formed a 
disulfide bond with C82. This indicates the possible heterogeneity of disulfide bond arrangement 
in Armet.  
 ER stress and cancer 
Poorly vascularized solid-tumor cells encounter a range of cytotoxic conditions such as 
hypoxia and nutrient starvation which alter the physiological environment of the ER. 
Accumulation of misfolded protein in the ER will activate the UPR (Ma et al., 2004). In vitro 
activation of the UPR decreases the sensitivity of cancer cells to treatments (Ma et al., 2004) 
(Healy et al., 2009). It is known that UPR is activated in breast tumors (Fernandez et al., 2000), 
hepatocellular carcinomas (Shuda et al., 2003), and gastric tumors (Song et al., 2001) with up-
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regulation of ER chaperones such as Grp78. XBP1, an ER stress-induced protein was reported to 
be necessary to tumor growth in vivo (Romero-Ramirez et al., 2004). More comprehensive 
studies need to be done to identify which component is most important in relative pathways, how 
large a role the UPR has in tumor growth, and at which stages of tumor development are 
regulated by UPR proteins. Although Armet is involved in reacting to ER stress, nothing is 
known about how it interacts with other components in UPR signaling, and how it is important in 
cancers.  
 Goal of this study 
The research presented in this thesis is intended to provide information on the 
intracellular localization, biochemical and biophysical properties of human Armet. Such 
information will contribute to a better understanding of Armet’s function and to future studies 
such as the binding of chemical ligands to Armet. 
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Chapter 2 - Methods  
 Recombinant human Armet expression and purification 
N-terminal 6X His-tagged human Armet gene without signal peptide was amplified by 
PCR from plasmid containing C-terminal 6×His-tagged human Armet gene using primers 5’-
GCCCATGGGCCACCACCACCACCACCACctgcggccgggcgac-3’ and 5’- 
GGCCCTCGAGCTACAAATCGGTCCG-3’. The PCR product was cloned into pET-28a-c(+) 
vector using NcoI and XhoI sites. Cloned Armet was confirmed by sequencing. To express 
protein, Escherichia coli strain BL21 (DE3) transformed with the recombinant plasmid was 
cultured at 37 ℃ using LB medium until OD 600 reached 0.6. Induction of the recombinant 
protein was performed with 1 mM IPTG for 4 hr at 30 ℃. Cells were harvested and resuspended 
in 50 mM Na2HPO4, 300 mM NaCl, 10 mM immidazole, pH 8.5. After sonication, the resulting 
lysates were centrifuged at 14,000 g for 20 min. The supernatant was loaded on Ni-NTA column. 
Impurities were eluted by 40 column volume of 50 mM Na2HPO4, 300 mM NaCl, 20 mM 
immidazole. Then N-terminal 6X His-tagged human Armet were eluted by 5 column volume of 
50 mM Na2HPO4, 300 mM NaCl, 300 mM immidazole followed by dialysis overnight at 4 ℃ 
with 50 mM Tris-HCl, 100 mM NaCl, pH 7.0. 
To express 
15
N labeled protein, Escherichia coli strain BL21 (DE3) transformed with the 
recombinant plasmid was cultured at 37 ℃ using M9 medium (12.8 g Na2HPO4·7H2O, 3 g 
KH2PO4, 0.25 g NaCl, 1 g 
15
NH4Cl in 1 L distilled H2O, autoclaved) with filter sterilized 2ml of 
1 M MgSO4, 20 mL of 20 % glucose, 100 uL of 1 M CaCl2 until OD 600 reached 0.6. Induction 
of the recombinant protein was performed with 1 mM IPTG for 24 hr at 30 ℃. 
 Western blot analysis 
Purified human Armet polyclonal antibody was obtained from R&D Systems (Lot 
YLB0207081). The antigen was mouse myeloma cell line NS0 derived recombinant human 
MANF consisted of Leu22-Leu179 and the antibody was raised in goat. 
Protein samples were incubated for 5 min in boiling water, and then loaded in a 12% 
acrylamide gel and run on constant voltage of 80 V for approximately 30 min, and run on 
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constant voltage of 180 V for another 1 hr. The separated proteins on the gel were transferred on 
a nitrocellulose membrane using a half-dry transfer cell. The membrane was incubated in 5% 
instant non-fat dry milk in TBST for 1hr for non-specific protein binding site blocking. The 
membrane was then incubated with purified anti-human Armet antibody at 1:1000 dilution in 
TBST containing 5% non-fat dry milk overnight. In the next morning, the membrane was 
washed with TBST 3 times, at 5 min per wash. The membrane was then incubated with rabbit 
anti-goat IgG (H+L)-AP conjugate (Bio-Rad Laboratories) at 1:3000 in TBST for 1 hr at room 
temperature. The membrane was again washed 3 times and developed with the AP conjugate 
substrate kit (Bio-Rad Laboratories). 
 Immunofluorescence microscopy 
Human MDA –MB-231 cells were fixed by 4% paraformadehyde. Fixed cells were 
washed with PBS 3 times and incubated in 1% Triton X-100 for 10 min. After 3 washing times 
with PBS, cells were blocked with 1% BSA in PBS for 1hr at room temperature. Then 1% BSA 
was removed and cells were incubated with purified goat anti-human Armet IgG (R&D Systems) 
and rabbit anti-58K Golgi protein IgG (Sigma-Aldrich) at 1:200 dilution in PBS with 5% non-fat 
dry milk overnight at 4 ℃. In the next morning, the first antibodies were removed. Then cells 
were washed with PBS 3 times and incubated with donkey anti-goat IgG (Alexa Fluor® 488, 
Invitrogen ) and goat anti-rabbit IgG (Rhodamine Red
TM
-X, Invitrogen) at 1:250 in PBS along 
with 1:5000 DAPI for 1 hr. After incubation, the secondary antibody and 4',6-diamidino-2-
phenylindole (DAPI) were aspired and cells were washed 3 times with PBS. The coverslips were 
moved to filter papers and air dried before they were mounted with prolong antifade mounting 
solution. Photographs were taken using Leica DMI6000 B inverted microscope and analyzed by 
LAS AF (Leica application suite advanced fluorescence) software.  
 Circular dichroism (CD) spectroscopy 
CD spectroscopy was performed with a Jasco 815 spectropolarimeter (Jasco, Tokyo, 
Japan) using a 0.1 cm path length cell over the 190-260 nm range. The spectra were acquired at 
room temperature every 1 nm with a 2 sec per data point and a 1 nm band pass. N-terminal 6X 
His-tagged human Armet was dissolved in 50 mM Tris-HCl, 100 mM NaCl, pH 7.0.  
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 Differential scanning calorimetry (DSC) analysis  
The effect of Ca
2+
 on thermal stability of human Armet in different buffer conditions was 
studied using a MicroCal VP-DSC calorimeter. Armet 1.5 mg/mL was dialyzed against 50 mM 
Tris-HCl, 100 mM NaCl, pH 7.0, 5 mM CaCl2·2H2O; or against 50 mM Tris-HCl, 100 mM NaCl, 
pH 7.0, 2 mM EDTA. The dialysate buffers were placed in the reference cell during experiments. 
The cell pressure was set at 30 psi; the scan rate was set to 60 K/hr; and the scan range was 25-
110 ℃. Prior to the scanning of protein samples, the baseline was checked using the dialysate 
buffers in both sample and reference cells. All scans were repeated four times on each protein 
sample. Data were analyzed using the “Origin for DSC”software.  
 Nuclear magnetic resonance (NMR) spectroscopy  
NMR experiments were performed on a 500 MHz Varian NMR system spectrometer at 
25 ℃. In calcium binding experiments, 2D 1H-15N HSQC spectra were acquired after addition of 
EDTA and CaCl2·2H2O to 0.3 mM 
15
N labeled N-terminal 6X His-tagged human Armet in 50 
mM Tris-HCl, pH 7.0. NMR data were analyzed by using MestReNova software.   
 Mass spectrometry  
A protein solution was mixed with 3X volume of acetone in ice. After protein precipitate 
was collected and dissolved with 2% acetonitrile in 0.1 % trifluoroacetic acid solution. Then, 1.0 
μL of the protein solution was dispensed along with 1.0 μL of 20 mg/mL DHB (Fluka/Sigma, St. 
Louis, MO) onto a stainless steel target plate. MALDI TOF spectra were acquired with a Bruker 
Ultraflex II (Bruker Daltonics)  using Bruker protein molecular weight standard I (Bruker 
Daltonics) for molecular weight calibration. 
 Analytical ultracentrifuge (AUC) 
Sedimentation velocity experiments were conducted using an Optima XL-I 
ultracentrifuge using the An-60 Ti rotor at 20 ℃. Protein samples were dialyzed against Tris 
buffer (50 mM Tris, 100 mM NaCl, pH 7.0); Tris buffer with 5 mM CaCl2·2H2O; or Tris buffer 
with 5 mM DTT before apply to AUC experiments. Sedimentation was monitored at 280 nm 
using double sector cells with a sample volume of 400 μL per cell. Sedimentation was at 49,000 
rpm with scans made at 5 min intervals. Sedimentation data were analyzed using DCDT+ 
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software version 1.16 and sedimentation coefficients were calculated by using g(s*) fitting 
function in DCDT+ software. 
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Chapter 3 - Results 
 Immunofluorescence microscopy 
Immunofluorescence microscopy was used to study the intracellular localization of 
Armet in human MDA-MB-231 cells. In Fig. 3.1, Armet was stained green and the Golgi was 
stained red. The staining of Armet was weaker in the periphery of cells and somewhat 
concentrated with the Golgi maker. It indicates Armet is localized in the Golgi and ER. 
 Expression and purification of human Armet 
The N-terminal His-tagged fusion Armet was expressed in E. coli BL21 (DE3). High 
expression levels of recombinant protein were obtained after 1 mM IPTG induction (Fig. 3.2). 
His-tagged Armet was purified using a Ni
2+
-affinity column. The purity was checked by SDS-
PAGE (Fig. 3.2). With treatment of β-mercaptoethanol, one major band was observed with a 
molecular weight around 20 kDa. Without treatment with β-mercaptoethanol, two major bands 
with very similar migration distance were observed in the purified Armet, and a molecular ladder 
of higher molecular weight bands was observed. 
In the cell lysate of induced E.coli, two bands with molecular masses close to 20 kDa 
were observed in SDS-PAGE and western blotting, but only in the absence of β-mercaptoethanol. 
Similar to the purified sample, a molecular ladder was also observed (Fig. 3.12, Fig. 3.13). The 
observations in the supernatant after sonication were consistent with the results of induced E.coli 
cells dissolved directly in the SDS sample buffer.   
 Ca2+-induced conformational changes of Armet 
The CD spectrum of Armet did not change after EDTA was added (Fig. 9). CD spectra of 
Armet in several Ca
2+
 concentrations were collected. Armet exhibited spectral changes during 
the titration of Ca
2+
. In the Ca
2+ 
titration, conformational changes of Armet were detected at 
millimolar levels of Ca
2+
 (Fig. 3.4). Binding of Ca
2+ 
by Armet was monitored by measuring 
negative molar ellipticity at 208 nm and 222 nm as a function of Ca
2+
 concentration. If we 
assume a single binding model, the dissociation constant would be in the millimolar range.  
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 Thermal denaturation of Armet in the presence and absence of Ca2+  
The first scan of Ca
2+ 
free Armet showed one peak centered at 83 ℃. This corresponds to 
the melting temperature of the protein. The peak disappeared in the second scan (Fig. 3.5). This 
indicates that the unfolded Armet does not renature after heat denaturation. In the DSC spectrum 
of Ca
2+
 bound Armet, a smaller peak was observed, also centered at 83 ℃ (Fig. 3.5). This 
indicates the Tm of Armet did not change upon Ca
2+
 binding, but the protein was somewhat less 
structured.  
 Ca2+ binding examined by NMR 
2D 
1
H-
15
N HSQC spectra were recorded for Armet in 50 mM Tris-HCl, pH 7.0 in the 
presence (8 mM) and absence of calcium (with 2 mM EDTA). Changes in chemical shift 
changes and signal intensity were observed (Fig. 3.6, Fig. 3.7, Fig. 3.8). After Ca
2+
 binding, 
chemical shift changes were observed in Gln18, Lys84, Lys114, and Glu132. Residues with 
increased signal strength included Gly55, His75, Ser134, Ser153, and Thr156. Residues with 
decreased signal strength included Asp5, Ile32, Ile37, Leu50, Asp58, Asp68, Ile76, Ile81, Tyr97, 
Ile101, Thr105, Ile135, Arg138, Asp157, and Leu158 (Fig. 3.9, Fig. 3.10). The observation 
suggested the binding of Ca
2+ 
to Armet.  
 Molecular mass analysis by MALDI-TOF-MS 
The mass of purified N-terminal His-tagged Armet was determined by matrix-assisted 
laser desorption/ionization (MALDI)-time-of-flight (TOF) mass spectrometry. Calculated 
molecular mass of the recombinant protein is 19,173 Da without the N-terminal Met. Masses 
obtained from the Ni-NTA purified protein sample were 19,038.808 Da (the main component), 
19,136.514 Da, and 19,218.079 Da (Fig. 3.16).  
SDS-PAGE without treatment of β-mercaptoethanol was used to separate two forms of 
Armet (Fig. 8). After electrophoresis, two bands with masses close to 20 kDa were cut out and 
analyzed by MALDI-TOF-MS. The detected mass of the lower band was 19048.74 Da, and the 
detected mass of the upper band was 19054.011 Da (Fig. 3.15). The result suggested the different 
migration properties of these two bands on SDS-PAGE were not caused by different masses.                      
 
Ultracentrifugation 
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Sedimentation velocity at different buffer conditions was performed. In the purified 
protein sample, one peak was observed at 2 S and a smear was observed around 4 S. This 
suggested that most protein was in the monomer form, and a small portion of protein was in the 
oligomer form. No change was observed after Ca
2+ 
was added. With 5 mM DTT, the smear 
around 4 S disappeared when the peak at 2 S increased (Fig. 3.17).  From the plot of 
log(sedimentation constant) against log(molecular weight) (Halsall et al., 1982), sedimentation 
constant for Armet as a monomer (19,173 Da) is around 2.4, which is close to observed 
sedimentation coefficient of about 2 S. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
13 
 
 
Chapter 4 - Discussion and Conclusions 
 Intracellular localization of human Armet 
Armet, a secreted protein, is expected to occur in the ER. And some evidence indicates 
Armet is, to some extent, retained in the ER. A C-terminal ER retention signal, RTDL, is 
conserved in amphibian and mammal Armet, and other KDEL-like sequences are also are found 
in insect Armet. 
Secreted Armet was first found in a rat mesencephalic type-1 astroycte cell line culture 
medium as a neurotrophic factor (Petrova et al., 2003). In an immunofluorescence study, Armet 
was colocalized with ER resident protein disulfide isomerase in Balb/c 3T3 cells and was easily 
extracted from microsomes in alkaline extraction. This indicated Armet was an ER protein that 
was not bound to the membrane (Mizobuchi et al., 2007). Apostolu et al. (2008) showed in Hela 
cells transfected with ER protein Hrd1that Armet was found colocalized with Hrd1 and Golgin-
97, a Golgi marker by immunofluorescence staining.  
In a study of different C-terminal KDEL-like motifs, Raykhel et al. (2007) found C-
terminal RTDL resulted in the efficient ER localization of a reporter construct with an N-
terminal secretion signal. Immunofluorescence localization of the protein encoded by this 
construct was mainly found in the ER and little was found in the Golgi (Raykhel et al., 2007).  
In this work, double immunofluorescent staining of Armet and a Golgi in human breast 
cancer MBA-MD-231 cells was performed. The staining of endogenous Armet was weaker in 
the periphery of the cells than near the nucleus where it colocalized with the Golgi maker. This 
indicated Armet was localized in the Golgi and presumably also in the ER. Our result, combined 
with other groups’ observations, suggests that Armet is found in ER not only because it is a 
secreted protein, but also because it is retained in the ER. Armet’s localization indicates its 
potential function in the ER during ER stress.  
 Ca2+ binding of human Armet 
Previously in our lab, Dr. Feng Cui found that Armet from pea aphid was a calcium 
binding protein. In this study, several biophysical techniques were used to explore a possible 
interaction between human Armet and calcium ion. The CD spectrum of purified Armet protein 
14 
 
showed negative peaks at 208 nm and 222 nm, which indicated a characteristic α-helix. In the 
presence of Ca
2+
, the ellipticity at 208 and 222 nm decreased. This suggests a structural change 
due to helix-helix interactions (Mani et al., 1982, Santamaria-Kisiel et al., 2011). The free Ca
2+
 
concentration in the ER intraluminal space varies from 0.2-1 mM (Verkhratsky et al., 2003). 
Some ER proteins are Ca
2+
-binding proteins such as calreticulin and calnexin (Michalak et al., 
2002). Their calcium binding affinity is mostly in micromolar range. KD values of a common 
calcium binding motif, EF hand, are in micromolar range as well (Hebenstreit et. al, 2005). 
Calcium binding by an ER protein with low affinity and high capacity is also reported. For 
example, calreticulin can bind calcium with KD values of 17 μM and 0.6 mM (Wijeyesakere et 
al., 2010).  
The DSC results seem consistent with the CD results. Without Ca
2+
, one peak was 
observed, centered at 85℃. With 5 mM Ca2+, a smaller peak was detected at the same 
temperature. This indicated the melting temperature of Armet did not change upon Ca
2+
-binding, 
but less structure existed in the protein with calcium bound.  
In sedimentation velocity experiments, Ca
2+
 did not increase the content of oligomers 
formed in purified Armet sample. This indicated that Ca
2+
 induced protein conformational 
change that did not affect interaction between Armet molecules. 
In 2D 
1
H-
15
N HSQC spectra of Armet, peak intensity changes and perturbation of peak 
chemical shifts verified the binding between Armet and Ca
2+
. Around 30 of the 120 detected 
peaks were significantly changed after Ca
2+ 
was added. The residues losing intensity of HSQC 
crosspeaks had reduced mobility upon Ca
2+
 binding. Perturbations of residue chemical shifts 
indicated the change of chemical environment around these affected residues. From sequence 
alignment (Fig. A.7), negatively charged residues (Asp5, Asp121, Glu132, Asp135, Asp157) 
perturbed upon calcium binding are conserved. Although no traditional calcium binding motif 
exists in Armet, affected amino acid residues Glu132 and Asp135 could form part of a cluster of 
negatively charged side chains that could possibly form a binding site for a calcium ion. Due to 
flexibility of the linker region of Armet, it is also possible that Asp157 at the C-terminus could 
interact with other residues with negatively charged side chains to form another calcium binding 
site.  
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 Heterogeneity of human Armet 
Eight conserved cysteines were found in all Armets. Four cysteines participate in two 
CXXC motifs. CXXC motifs occur in disulfide isomerases and may indicate similar function in 
Armet (Parkash et al., 2010). But the α-helix rich structure of Armet is very different from the 
thioredoxin fold (an α/β structure) (N. Mizobuchi et al., 2007). A heterogeneity of disulfide 
bonds in mouse Armet was described in previous publications, but not discussed.  Using 
MALDI-TOF MS, Mizobuchi et al. (2007) identified three intramolecular disulfide bonds at 
Cys6-Cys9, Cys 40-Cys51, and Cys 127-130. In another MALDI-TOF MS study, Hoseki et al. 
(2010) suggested disulfide bonds at Cys6-Cys93/Cys9-Cys93, Cys6-Cys82/Cys9-Cys82, Cys40-
Cys51, and Cys127-Cys130 (Table 4.1). 
No disulfide bond heterogeneity in human Armet has been reported. In this study, two 
bands of slightly different mobility were observed in SDS gels run in the absence of reducing 
agent on purified Armet. Molecular weight analysis by MALDI-TOF MS showed these two 
bands had masses of 19048.74 Da and 19054.011 Da. Thus the mobility difference for the two 
bands is not due to differences in mass. I suggest that mobility difference might due to alternate 
disulfide bonds arrangement. Also, without any reducing reagent, a faint ladder was formed by 
Armet in SDS gels and westenblottings. The calculated masses of bands in the ladder are 38 and 
60 kDa from westernblotting (Fig. 3.13). This indicates about 12% (calculated form SDS gels) 
purified Armet formed oligomers. Disappearance of the ladder in the presence of reducing agent 
indicated formation of disulfides between Armet molecules. Sedimentation velocity experiments 
also suggested a portion of Armet formed oligomers though intermolecular disulfide bonds in 50 
mM Tris-HCl, 100 mM NaCl, pH 7.0. These results indicate existence of free cysteines in 
Armet’s expression in E.coli. In the study of human Armet’s crystal structure, the protein was 
crystallized as monomer at 4℃ in 100 mM Na-cacodylate buffer, pH 6.5, 0.2 M MgAc2 and 12–
18% (w/v) PEG 8000 (Parkash et al., 2010). The monomer observed in crystal structure might be 
explained as effect of temperature.  Whether Armet can form oligomeres in mammalian cells 
needs to be studied. 
Finally, minor species of mass differences of 98 and 180 with respect to the main protein 
component were observed by MALDI-TOF MS. Perhaps this can be explained by 
phosphorylation modification of some amino acid residues. 
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 Conclusions and future work 
Results from CD and NMR indicate that human Armet is a calcium binding protein. 
Calcium binding could cause conformational change and loss of CD signal in the protein. DSC 
results indicated Armet was less structured upon calcium binding. The next logical step is to 
make mutants to verify those hypothetical binding sites. Negatively charged residues (Asp5, Asp 
121, Glu 132, Asp 135 and Asp157) with perturbed crosspeaks in NMR experiments might form 
calcium binding sites.  It is interesting to test whether mutants in these positions will affect 
Armet’s calcium binding property. These negatively residues can either be alternated by neutral 
Asn or Gln residues or to the small Gly residue. Mutations could also be made in the linker 
region because its flexibility might be involved in ligand binding of Armet. Within residues in 
the linker region, Lys114’s crosspeak showed the most significant change in the HSQC spectrum 
upon calcium binding of Armet. An experiment could be done with Lys114-Pro114 mutant to 
reduce flexibility of the linker region.  
Three types of heterogeneity of Armet were found in this study. In recombinant E.coli 
cells and extract, two Armet species were detected with possible different disulfide bond 
arrangements. A ladder formed by Armet linked with intermolecular disulfide bonds was 
observed. And mass heterogeneity of Armet was also detected. Whether two species of Armet 
and the ladder exist in human cell needs to be studied by westernblotting with and without ER 
stress.  
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Figure 1.1 Alignment of Armet from vertebrates and invertebrates. 
Residues highlighted in yellow are cysteines. C-terminal ER retention signals are highlighted in 
Pink. The stars, dots and colons below the alignment sequences indicate the level of similarity at 
each position.  
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Figure 1.2 Alignment of full-length human and mouse Armets. 
N-terminal signal peptides are colored in blue. Residues highlighted in yellow are cysteines. 
Residues that are different in human and mouse Armets are highlighted in gray. C-terminal ER 
retention signals are highlighted in Pink. 
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Figure 1.3 Recombinant plasmid and sequence of N-terminal 6X His-tagged mature human 
Armet expressed in E.coli. 
Sequence of mature human Armet was cloned in pET-28a(+) plasmid between NcoI and XhoI 
restriction enzyme cleavage sites (highlighted in blue in the plasmid map). Six-histidine tag is 
highlighted in blue, eight cysteines are highlighted in yellow, and the C-terminal ER retention 
signal is highlighted in pink.  
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Figure 1.4 Crystal structure of human Armet (residue 1 to 137) (Parkash et al., 2009). 
Helices are shown as cylindrical structure. Side chains of conserved cysteines are colored blue.  
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Figure 1.5 Three dimensional structures of human and mouse Armet. 
(1) Crystal structure of human Armet (Parkash et al., 2009). 
(2) NMR structure of human Armet (Hellman et al., 2010). 
(3) NMR structure of mouse Armet (Hoseki et al., 2010). 
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Figure 1.6 Structural superimposition of Armets. 
(1) Superimposition of NMR and crystal structures of human Armet (NMR structure is gold and 
crystal structure is blue). 
(2) Superimposition of NMR structures of human and mouse Armet (Human Armet structure is 
gold and mouse Armet structure is green).  
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Figure 3.1 Armet localization in human MDA-MB-231 cells. 
(1) Immunofluorescence staining of Armet using goat anti-human Armet human antibodies and 
donkey-anti goat IgG.  
(2) Immunofluorescence staining of Golgi using rabbit anti-58K Golgi protein antibodies and 
goat anti rabbit IgG. 
(3) Overlay of Armet (green) and Golgin-97 (red) stained images. 
(4) Immunofluorescence staining of Armet, Golgi, and nuclei. Nuclei were stained in blue using 
DAPI. 
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Figure 3.2 SDS gel electrophoresis of samples from N-terminal 6X His-tagged human 
Armet expressed in E. coli and purified by Ni-NTA. 
Lane 1: molecular mass ladders. 
Lane 2: E. coli cells without IPTG induction.  
Lane 3: E. coli cells with 1mM IPTG induction. 
Lane 4: Induced E. coli supernatant after sonication. 
Lane 5: Flowthrough from Ni-NTA column.  
Lane 6: Purified protein in 50 mM Tris-HCl, 100 mM NaCl, pH 7.0. 
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Figure 3.3 Far UV CD spectra of Armet in the presence and absence of EDTA  
Armet sample was prepared in 50 mM Tris, 100 mM NaCl, pH 7.0. Protein concentration was 
0.03 mM. EDTA concentration was 1 mM.  
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Figure 3.4 Far UV CD spectra of Armet in the presence of EDTA and Ca
2+
. 
Armet samples were prepared in 50 mM Tris-HCl, 100 mM NaCl, pH 7.0. Protein concentrations 
were 0.013 mM (1) and 0.0166 mM (2). 
(1) and (2) are two independent experiments. 
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Figure 3.5 Differential scanning calorimetry of Armet in the presence of EDTA and Ca2+. 
Armet samples were prepared in 50 mM Tris-HCl, 100 mM NaCl, pH 7.0. Protein concentration 
was 0.04 mM. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
39 
 
 
 
 
 
 
 
 
 
 
 
                                                          1 
 
 
 
 
 
 
 
 
 
 
 
                                                          2 
 
 
 
 
 
 
 
 
20 30 40 50 60 70 80 90 100 110 120
-0.0014
-0.0012
-0.0010
-0.0008
-0.0006
C
p
(c
a
l/
o
C
)
Temperature (
o
C)
 with 5 mM EDTA, first scan
 with 5 mM EDTA, second scan
20 30 40 50 60 70 80 90 100 110 120
0.0004
0.0006
0.0008
0.0010
0.0012
0.0014
C
p
(c
a
l/
o
C
)
Temperature (
o
C)
 with 5 mM Ca
2+
, second scan
 with 5 mM Ca
2+
, first scan
40 
 
 
Figure 3.6 2D 
1
H-
15
N HSQC spectrum of Armet. 
Buffer: 50 mM Tris-HCl, 2 mM EDTA, pH 7.0. Protein concentration was 0.23 mM. Spectrum 
was recorded at 35 ℃.   
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Figure 3.7 2D 
1
H-
15
N HSQC spectrum of Ca
2+
-bound Armet. 
Buffer: 50 mM Tris-HCl, 2 mM EDTA, 10 mM CaCl2, pH 7.0. Protein concentration was 0.3 
mM. Spectrum was recorded at 35 ℃.   
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Figure 3.8 Overlaid 2D 1H-15N HSQC spectra of Armet in the absence and in the presence 
of Ca
2+
. 
Black: Armet without Ca
2+
. 
Red: Armet with Ca
2+
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Figure 3.9 2D 
1
H-
15
N HSQC difference spectrum of Armet. 
Blue: Peaks with decreased signal strength in the presence of Ca
2+
. 
Red: Peaks with increased signal strength in the presence of Ca
2+
.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
47 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
48 
 
 
Figure 3.10 2D 
1
H-
15
N HSQC difference spectrum of Armet. 
Residues with significant changes are labeled using HSQC spectrum in previous human Armet 
NMR study (Hellman et al., 2010). 
Blue: Peaks with decreased signal strength in the presence of Ca
2+
. 
Red: Peaks with increased signal strength in the presence of Ca
2+
.
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Figure 3.11 Residues in Armet with changed 2D 
1
H-
15
N HSQC signals in the presence of 
Ca
2+
. 
(1) and (2): Perturbed glutamic acid and aspartic acid residues were colored in blue. 
(3) and (4): Perturbed amino residues in Ca
2+
-bound Armet. Residues with perturbed chemical 
shifts were colored in green, residues with increased signal were colored in pink, and residues 
with decreased signal were colored in blue. 
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Figure 3.12 SDS gel electrophoresis of human Armet during expression and purification.  
Lane 1: molecular mass markers.  
Lane 2: E. coli cells with 1mM IPTG induction. 
Lane 3: E. coli cells with 1mM IPTG induction (without mercaptoethanol). 
Lane 4: Induced E. coli supernatant after sonication. 
Lane 5: Induced E. coli supernatant after sonication (without mercaptoethanol). 
Lane 6: Induced E. coli pellet after sonication. 
Lane 7: Induced E. coli pellet after sonication (without mercaptoethanol). 
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Figure 3.13 Western blot of Armet in expression and purification.  
Lane 1: E. coli cells with 1mM IPTG induction. 
Lane 2: E. coli cells with 1mM IPTG induction (without mercaptoethanol). 
Lane 3: Induced E. coli supernatant after sonication. 
Lane 4: Induced E. coli supernatant after sonication (without mercaptoethanol). 
Lane 5: Induced E. coli pellet after sonication. 
Lane 6: Induced E. coli pellet after sonication (without mercaptoethanol). 
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Figure 3.14 A plot of log MW vs relative mobility from western blot in Figure 3.13.   
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Figure 3.15 Armet mass determination by MALDI-TOF-MS. 
Armet samples were prepared in 50 mM Tris-HCl, 100 mM NaCl, pH 7.0. Protein concentrations 
were 0.013 mM.  
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Figure 3.16 Armet mass determination by MALDI-TOF- MS. 
The upper band and lower band were extracted from the SDS gel (Fig. 8, lane 8). MS spectra 
were collected for both bands. 
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Figure 3.17 Sedimentation velocity experiments on Armet.  
Buffer: 50 mM Tris, 100 mM NaCl, pH 7.0. Spectra were collected for Armet, Armet in the 
presence of DTT, and Armet in the presence of calcium.  
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Table 4.1 Disulfide bridges reported in human and mouse Armet. 
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 Human Armet Mouse Armet 
X-ray 
crystallography 
Cys6-C93, Cys9-C82, Cys40-Cys51, Cys127-
Cys130 (Parkash et al., 2009) 
 
NMR Cys6-Cys93, Cys9-Cys82, Cys40-Cys51, 
Cys127-Cys130 (Hellman et al., 2010) 
Cys6-Cys93, Cys9-Cys82, Cys40-Cys51, Cys127-Cys130 
(Hoseki et al., 2010) 
MALDI-TOF 
MS 
 Cys6-Cys93, Cys9-Cys82, Cys40-Cys51, Cys127-Cys130 
(Hoseki et al., 2010). 
Cys6-Cys9, Cys82-Cys93, Cys40-Cys51, Cys127-Cys130 
(Mizobuchi et al., 2007) 
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Appendix A - Supplementary data  
 Sphingomyelin binding of Armet studied by NMR 
2D 
1
H-
15
N HSQC spectra were recorded for Armet in the presence (3 mM) and in the 
absence of sphingomyelin (Fig. A. 1, Fig. A. 2). After sphingomyelin binding, changes of 
chemical shift were observed in Glu100 and Leu158. Residues with decreased signal strength 
included Gln18, Arg41, Asn66, Gln91, Gln100, Lys109, Leu111, Asp115, Lys118, Trp123, 
Cys130, Glu132, Asn141, Leu143, Lys146, Arg155, and Glu157 (Fig. A. 3, Fig. A. 4).  
 HSQC NMR spectra of Armet in different conditions 
2D 
1
H-
15
N HSQC spectra of Armet were recorded with different buffer condition and 
with different potential chemical ligands.  No significant changes in spectra were detected after 
adding cefoperazone (Fig. A.8, Fig. A.9) or aminophenazone (Fig. A.10, Fig. A.11) to Armet 
sample. It indicates there is no binding between Armet and these chemicals.  
  Calcium binding of Armet studied by isothermal titration calorimetry (ITC) 
Calcium binding of Armet was studied by ITC (Fig. A.13). Data fitting by using “Origin 
for ITC” software (Fig. A.13) suggests two binding sites. Binding constants for one site is in 
milimolar range and for the other one is in micromolar range. Both hypothetical binding sites 
bind one calcium ion.  
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Figure A.1 2D 
1
H-
15
N HSQC spectrum of Armet. 
Buffer: 25 mM Tris-HCl, pH 7.0. Protein concentration was 0.3 mM. Spectrum was recorded at 
35℃.   
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Figure A.2 2D 
1
H-
15
N HSQC spectrum of sphigomyelin-bound Armet. 
Buffer: 25 mM Tris-HCl, pH 7.0. Protein concentration was 0.3 mM. Spectrum was recorded at 
35℃. Sphingomyelin concentration was 3 mM. 
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Figure A.3 Overlaid 2D 1H-15N HSQC spectra of Armet in the absence and in the presence 
of sphingomyelin. 
Black: Armet without sphingomyelin. 
Red: Armet with sphingomyelin. 
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Figure A.4 2D 
1
H-
15
N HSQC difference spectrum of Armet. 
Blue: Peaks with decreased signal strength in the presence of sphingomyelin. 
Red: Peaks with increased signal strength in the presence of sphingomyelin.
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Figure A.5 2D 
1
H-
15
N HSQC difference spectrum of Armet. 
Blue: Peaks with decreased signal strength in the presence of sphingomyelin. 
Red: Peaks with increased signal strength in the presence of sphingomyelin.
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Figure A.6 Residues in Armet with changed 2D 
1
H-
15
N HSQC signals in the presence of 
sphingomyelin. 
Perturbed amino acid residues are blue. 
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Figure A.7 Perturbed Asp and Glu residues are conserved in Armets. 
N-terminal secretion signals are blue. C-terminal ER retention signals are pink. Conserved 
Cysteines are yellow. Perturbed Asp and Glu residues are green. 
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Figure A.8 2D 
1
H-
15
N HSQC spectrum of Armet with cefoperazone. 
Buffer: 50 mM BisTris, 150 mM NaCl, pH 6.5. Protein concentration was 0.3 mM. 
Cefoperazone concentration was 3 mM. 
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Figure A.9 2D 
1
H-
15
N HSQC difference spectrum of Armet with cefoperazone. 
Blue: Peaks with decreased signal strength in the presence of cefoperazone. 
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Figure A.10 2D 
1
H-
15
N HSQC spectrum of Armet with Aminophenazone. 
Buffer: 50 mM BisTris, 150 mM NaCl, pH 6.5. Protein concentration was 0.3 mM. 
Aminophenazone concentration was 3 mM. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
92 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
93 
 
 
Figure A.11 2D 
1
H-
15
N HSQC difference spectrum of Armet with aminophenazone. 
Blue: Peaks with decreased signal strength in the presence of Aminophenazone. 
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Figure A.12 2D 
1
H-
15
N HSQC spectrum of 
15
N, 
13
C labeled Armet. 
Buffer: 25 mM Na2HPO4, 150 mM NaCl, pH 6.5. Protein concentration was 0.4 mM. Spectrum 
was recorded at 25℃.   
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Figure A.13 Calcium binding of Armet studied by isothermal titration calorimetry (ITC). 
Buffer: 50 mM Tris-HCl, 100 mM NaCl, pH 7. Protein concentration was 0.07 mM. 
(1): Titration of Armet with calcium. 
(2): Two binding sites data fitting of calcium binding.  
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